Atkins MB - Search Results

1

Management of cutaneous melanoma.

Tsao H, Atkins MB, Sober AJ. Tsao H, et al. Among authors: atkins mb. N Engl J Med. 2004 Sep 2;351(10):998-1012. doi: 10.1056/NEJMra041245. N Engl J Med. 2004. PMID: 15342808 Review. No abstract available.

2

Melanotropin receptors demonstrated in situ in human melanoma.

Tatro JB, Atkins M, Mier JW, Hardarson S, Wolfe H, Smith T, Entwistle ML, Reichlin S. Tatro JB, et al. J Clin Invest. 1990 Jun;85(6):1825-32. doi: 10.1172/JCI114642. J Clin Invest. 1990. PMID: 2347915 Free PMC article.

3

Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma.

Fallick ML, McDermott DF, LaRock D, Long JP, Atkins MB. Fallick ML, et al. Among authors: atkins mb. J Urol. 1997 Nov;158(5):1691-5. doi: 10.1016/s0022-5347(01)64097-7. J Urol. 1997. PMID: 9334580 Clinical Trial.

4

Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.

Gollob JA, Mier JW, Veenstra K, McDermott DF, Clancy D, Clancy M, Atkins MB. Gollob JA, et al. Among authors: atkins mb. Clin Cancer Res. 2000 May;6(5):1678-92. Clin Cancer Res. 2000. PMID: 10815886 Clinical Trial.

5

High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696.

Kirkwood JM, Ibrahim J, Lawson DH, Atkins MB, Agarwala SS, Collins K, Mascari R, Morrissey DM, Chapman PB. Kirkwood JM, et al. Among authors: atkins mb. J Clin Oncol. 2001 Mar 1;19(5):1430-6. doi: 10.1200/JCO.2001.19.5.1430. J Clin Oncol. 2001. PMID: 11230488 Clinical Trial.

6

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF. Balch CM, et al. Among authors: atkins mb. J Clin Oncol. 2001 Aug 15;19(16):3635-48. doi: 10.1200/JCO.2001.19.16.3635. J Clin Oncol. 2001. PMID: 11504745 Review.

7

A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma.

Atkins MB, Gollob JA, Sosman JA, McDermott DF, Tutin L, Sorokin P, Parker RA, Mier JW. Atkins MB, et al. Clin Cancer Res. 2002 Oct;8(10):3075-81. Clin Cancer Res. 2002. PMID: 12374674 Clinical Trial.

8

Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma.

Gollob JA, Veenstra KG, Parker RA, Mier JW, McDermott DF, Clancy D, Tutin L, Koon H, Atkins MB. Gollob JA, et al. Among authors: atkins mb. J Clin Oncol. 2003 Jul 1;21(13):2564-73. doi: 10.1200/JCO.2003.12.119. J Clin Oncol. 2003. PMID: 12829677 Clinical Trial.

9

Application of IL-2 and other cytokines in renal cancer.

McDermott DF, Atkins MB. McDermott DF, et al. Among authors: atkins mb. Expert Opin Biol Ther. 2004 Apr;4(4):455-68. doi: 10.1517/14712598.4.4.455. Expert Opin Biol Ther. 2004. PMID: 15102596 Review.

10

An evidence-based staging system for cutaneous melanoma.

Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF. Balch CM, et al. Among authors: atkins mb. CA Cancer J Clin. 2004 May-Jun;54(3):131-49; quiz 182-4. doi: 10.3322/canjclin.54.3.131. CA Cancer J Clin. 2004. PMID: 15195788 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results